Navigation Links
Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria
Date:9/19/2007

CHICAGO, Sept. 19 /PRNewswire/ -- Targanta Therapeutics Corporation today released detailed data from completed studies comparing the in vitro activity of its lead antibiotic drug candidate, oritavancin, to that of other antibiotics against a variety of susceptible and resistant strains of gram- positive bacteria. Results are being presented today at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) taking place in Chicago, IL. All posters highlighted below are being presented at 12:15 pm CDT.

Poster E-1617 is entitled "In Vitro Activity Profile of Oritavancin (ORI) Against Resistant Staphylococcal Populations From a Recent Surveillance Initiative." In this study, researchers examined clinical isolates of Staphylococcus aureus (n=5,008) and coagulase-negative staphylococci (n=862) collected in 2005-2006 from hospital sites in the U.S., Europe and Israel. Oritavancin was active against all staphylococcal isolates, including those with specific resistance phenotypes and including multi-drug resistant S. aureus, which were resistant to three or more of the following agents: ciprofloxacin, clindamycin, erythromycin, gentamicin, oxacillin, quinupristin- dalfopristin, trimethoprim-sulfa, vancomycin, daptomycin, and linezolid. Results from this study demonstrated that oritavancin had potent in vitro activity against a wide spectrum of staphylococci likely to be encountered in a variety of clinical settings.

Poster E-1613, entitled "In Vitro Activity Profile of Oritavancin (ORI) Against Organisms Demonstrating Key Resistance Profiles to Other Antimicrobial Agents," compared the activity of oritavancin to vancomycin and teicoplanin against a diverse collection of staphylococci and enterococci, including strains with elevated MICs to linezolid, daptomycin, and/or vancomycin, as well as strains of streptococci. Bacterial isolates included S. aureus (n=35), coagulase-negative staphylococci (n=21), Enterococcus faecalis (
'/>"/>

SOURCE Targanta Therapeutics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Targanta Study Shows Oritavancin Treatment Effective in a Mouse Model of Anthrax
2. Targanta Reports Improved Ability of Oritavancin to Stop Bacteria Growth In Vitro Compared With Other Glycopeptide Antibiotics
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
5. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
6. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
7. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
8. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
9. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
10. Cipralex demonstrates superiority to duloxetine for acute treatment of depression in new study
11. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 You,re visiting the dentist for what ... he or she says you need a root canal. ... may have several questions and feel apprehensive about your ... it,s nothing to worry about. The Pennsylvania Dental Association ... any anxiety the public may have surrounding this common ...
(Date:12/19/2014)... N.C. , Dec. 19, 2014 ... optimize a product,s web presence to reflect the ... websites, in particular, must meet the needs of ... and culture. According to recent ... than half of the participating companies averaged more ...
(Date:12/19/2014)... , December 18, 2014 ... software application/module that is used to store, manipulate, ... RIS comprises a patient tracking and scheduling system, ... integration of RIS with HIS and other databases ... patient registration and patient scheduling, patient list management, ...
Breaking Medicine Technology:Root Canals Have Become More Routine 2Building a Best-in-Class Pharma Global Brand Website 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3
... Pharmaceuticals, Inc. (NYSE Amex: ANX ) today announced ... private company that holds certain rights and know-how to poloxamer-based ... the target company. About the ... target company contemplate an all-stock acquisition by merger. Other than ...
... 2011 Amarin Corporation plc (Nasdaq: AMRN ... focus on cardiovascular disease, today announced that, in connection ... Depositary Shares ("ADSs"), the underwriters of the offering have ... an aggregate of 1,800,000 additional ADSs to cover over-allotments. ...
Cached Medicine Technology:ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics 2ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics 3ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics 4ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics 5Amarin Announces Underwriters' Exercise of Over-Allotment Option 2Amarin Announces Underwriters' Exercise of Over-Allotment Option 3Amarin Announces Underwriters' Exercise of Over-Allotment Option 4
(Date:12/21/2014)... Weddingshe.com, an outstanding online supplier of wedding dresses ... new selection of Cocktail Dresses for the winter 2014. ... newest fashion trends. , “We take pride ... . All of them are offered at greatly discounted ... every effort to offer a nice shopping experience for ...
(Date:12/21/2014)... 21, 2014 Hundreds of Byetta ... claims involving a class of Type 2 diabetes ... forward in a federal multidistrict litigation now underway ... Bernstein Liebhard LLP reports. According to an Order ... data cut-off date of February 27, 2014 for ...
(Date:12/21/2014)... 21, 2014 Serious Buyer, Andrew Hawley ... Jm Morrison and the Doors International Ballroom at the ... also be the only time that Morrison's mother would ... Nov. 25, 1967. According to Hawley, “This would be ... play the Alexandria Roller Rink earlier that year and ...
(Date:12/21/2014)... As testosterone therapy lawsuit filings on ... clots from using testosterone products such as AndroGel and ... the male hormone testosterone may increase the risk of ... the Proceedings of the National Academy of Sciences in ... male rats with naturally occurring colon cancer. Dr. Amos-Landgraf, ...
(Date:12/20/2014)... BambooIndustry.com is a leading eco-friendly bamboo ... its bamboo flooring promotion for the coming 2015. ... suppliers, and offers the best bamboo products and ... promotion, all customers can enjoy a special discount, ... know BambooIndustry.com from press releases. , The bamboo ...
Breaking Medicine News(10 mins):Health News:Stunning Cocktail Party Dresses from Weddingshe.com 2Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 2Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 3Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 4Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2
... -- Using human embryonic stem cells to treat the eye ... some vision improvement, a small, early-stage study found. The ... with different types of macular degeneration that had led to ... cell transplants seemed safe and both patients had some improvement ...
... An Indiana University School of Medicine study has ... than race on physician diagnosis of whether a child,s ... presented with scenarios that could possibly but not obviously ... States who participated in the study were most likely ...
... MONDAY, Jan. 23 (HealthDay News) -- If you,re unhappy ... aren,t being met by your manager or company, a ... to motivate workers and companies that don,t seem to ... competence and relatedness (how you relate to others), according ...
... Could preventing colon cancer be as simple as developing a ... Illinois study, scientists showed that human colon cancer cells die ... compounds present in one cup of this brew, which has ... "The caffeine derivatives in mate tea not only induced ...
... project to reduce throughout the beef production chain the occurrence ... threat to public health. The U.S. Department of Agriculture,s ... UNL on Monday, Jan. 23. The project targets Shiga-toxin ... than 265,000 illnesses in the United States annually. Eating contaminated ...
... professor is turning to nutrition to tackle prostate cancer. ... make more informed diet decisions by studying foods and dietary ... cancer is one of the most common forms of cancer ... researching ways to prevent prostate cancer rather than how to ...
Cached Medicine News:Health News:Small Stem Cell Study Claims Early Success in Treating Eye Disease 2Health News:Small Stem Cell Study Claims Early Success in Treating Eye Disease 3Health News:IU study: Socioeconomic status more influential than race in determination of child abuse 2Health News:Bosses Have Big Impact on Workplace Well-Being 2Health News:Compounds in mate tea induce death in colon cancer cells 2Health News:U. of Nebraska to lead $25 million project targeting E. coli threat 2Health News:U. of Nebraska to lead $25 million project targeting E. coli threat 3Health News:Eating smart: Researcher studies foods, dietary supplements that may reduce risk of prostate cancer 2
Ready to use liquid single reagent for automated chemistry analyzers. Linearity to 1000 mmol/L...
Ready to use liquid single reagent for automated chemistry analyzers. Linearity to 1000 mmol/L...
... Intended for the ... in plasma. Two vials, ... Enzymatic, alphaketoglutarate. Uses NADPH ... other plasma compounds. Reaction: ...
... Proteomeworks system is an integrated ... that enables protein function discovery. ... preparation, 2-D electrophoresis, staining, imaging ... automated protein digestion, mass spectrometry, ...
Medicine Products: